COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
作者信息
Gulati Kavita, Prendecki Maria, Clarke Candice, Willicombe Michelle, McAdoo Stephen
机构信息
Imperial College London, Imperial College NHS Trust, London, UK.
出版信息
Arthritis Rheumatol. 2021 Jun;73(6):1091-1092. doi: 10.1002/art.41671. Epub 2021 Apr 4.
Abstract
摘要
相似文献
1
COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.一名接受抗中性粒细胞胞浆抗体相关血管炎免疫抑制治疗的患者发生新冠病毒二次感染
Arthritis Rheumatol. 2021 Jun;73(6):1091-1092. doi: 10.1002/art.41671. Epub 2021 Apr 4.
2
COVID-19 Recovery Without B Cells or Antibodies in Patients Receiving Rituximab for Autoimmune Disease.COVID-19 恢复期患者在接受利妥昔单抗治疗自身免疫性疾病时无 B 细胞或抗体。
Iran J Kidney Dis. 2021 Mar;1(2):159-160.
3
Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.详细追踪抗中性粒细胞胞质抗体相关性血管炎免疫抑制患者 2019 冠状病毒病治疗期间的抗原和抗体水平。
J Infect Chemother. 2024 Sep;30(9):922-927. doi: 10.1016/j.jiac.2024.02.004. Epub 2024 Feb 10.
4
Pediatric P-ANCA vasculitis following COVID-19.儿童 COVID-19 后 P-ANCA 血管炎。
Pediatr Pulmonol. 2021 Oct;56(10):3422-3424. doi: 10.1002/ppul.25612. Epub 2021 Aug 11.
5
Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic.新冠疫情之前及期间抗中性粒细胞胞浆抗体阳性率
Rheumatol Int. 2024 Oct;44(10):1935-1940. doi: 10.1007/s00296-024-05596-3. Epub 2024 Apr 24.
6
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎患者接种第三剂BNT162b2新冠疫苗。
Ann Rheum Dis. 2022 Apr;81(4):593-595. doi: 10.1136/annrheumdis-2021-221747. Epub 2022 Jan 10.
7
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.利妥昔单抗治疗的抗中性粒细胞胞浆抗体相关性血管炎患者对新冠病毒加强疫苗的抗体反应
Kidney Int. 2022 Feb;101(2):414-415. doi: 10.1016/j.kint.2021.11.012. Epub 2021 Nov 22.
8
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti-neutrophil cytoplasmic antibody vasculitis.利妥昔单抗对抗中性粒细胞胞浆抗体血管炎患者针对新冠病毒加强疫苗的体液反应及抗体动力学的影响
Kidney Int. 2021 Nov;100(5):1124-1127. doi: 10.1016/j.kint.2021.08.020. Epub 2021 Sep 7.
9
An unusual presentation of C-ANCA vasculitis.C-ANCA 血管炎的一种不寻常表现。
QJM. 2012 Nov;105(11):1105-7. doi: 10.1093/qjmed/hcr169. Epub 2011 Sep 14.
10
Fatal haemorrhagic varicella in a patient with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.一名患有抗中性粒细胞胞浆抗体（ANCA）相关血管炎的患者发生致命性出血性水痘。
Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S95. Epub 2013 Feb 25.
引用本文的文献
1
COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature.肉芽肿性多血管炎中 COVID-19 的病程：单中心经验及文献复习。
Turk J Med Sci. 2022 Aug;52(4):899-909. doi: 10.55730/1300-0144.5389. Epub 2022 Aug 10.
2
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum.COVID-19 大流行与抗中性粒细胞胞浆抗体相关性血管炎——EUVAS 会议和 EUVAS 教育论坛的报告。
Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986. Epub 2021 Oct 28.
3
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战：对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.
4
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination.新冠疫苗接种后丙硫氧嘧啶诱发的抗中性粒细胞胞浆抗体相关性血管炎
Vaccines (Basel). 2021 Jul 31;9(8):842. doi: 10.3390/vaccines9080842.
5
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?新冠病毒抗体反应减弱：我们能从其他冠状病毒分析中学到什么？
Infection. 2022 Feb;50(1):11-25. doi: 10.1007/s15010-021-01664-z. Epub 2021 Jul 29.
本文引用的文献
1
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.癌症免疫抑制治疗后活的严重急性呼吸综合征冠状病毒2的脱落
N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1.
2
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.严重急性呼吸综合征冠状病毒2型在免疫功能低下宿主中的持续存在与演变
N Engl J Med. 2020 Dec 3;383(23):2291-2293. doi: 10.1056/NEJMc2031364. Epub 2020 Nov 11.
3
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染：一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
4
What reinfections mean for COVID-19.新冠病毒再感染意味着什么。
Lancet Infect Dis. 2021 Jan;21(1):3-5. doi: 10.1016/S1473-3099(20)30783-0. Epub 2020 Oct 12.
Zotero 插件